Biofrontera Inc.
BFRI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001858685
No open-market purchases or sales by Biofrontera Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $2.61M in total; no superinvestor holds it.
Other share classesBFRIW
Q3 2023 vs. Q2 2023
How the institutions holding Biofrontera Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 13 | 8 | −5 |
| Shares | 794.3K | 16.2K | −778.1K (−98.0%) |
| Value | $412.7K | $142.2K | −$270.4K (−65.5%) |
New holders (3)
Institutions that held Biofrontera Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cary Street Partner Investment Advisory LLC | 25 | $219 | 0.00% |
| JPMorgan Chase & Co | 1 | $9 | 0.00% |
| UBS Group AG | 1 | $9 | 0.00% |
Sold out (8)
Institutions that held Biofrontera Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Bard Associates Inc | 191,200 | $99.4K |
| Schonfeld Strategic Advisors LLC | 88,500 | $46.0K |
| Geode Capital Management, LLC | 81,282 | $42.3K |
| Renaissance Technologies LLC | 50,434 | $26.0K |
| State Street Corp | 22,900 | $11.9K |
| Northern Trust Corp | 20,728 | $10.8K |
| Tower Research Capital LLC (TRC) | 13,109 | $6.82K |
| Simplex Trading, LLC | 70 | $0 |